Kim Fox is Professor of Clinical Cardiology and Head of the National Heart and Lung Institute at Imperial College London. He is also Diana, Princess of Wales Chair in Cardiovascular Medicine and Science and Consultant Cardiologist at the Royal Brompton Hospital and Executive Chairman of the Institute of Cardiovascular Medicine and Science, a formal collaboration between the Royal Brompton and Harefield NHS Foundation Trust and Liverpool Heart and Chest NHS Foundation Trust. Professor Fox is also a non-Executive Director of the Royal Brompton and Harefield NHS Foundation Trust.
He was President of the European Society of Cardiology 2006-2008, having previously been Treasurer and Secretary. He was Associate Editor of the British Heart Journal in 1985-1994 and Editor in Chief of the European Heart Journal 1994-2002. He has previously served as a member of the British Heart Foundation Education Committee (chair), Council and Executive Committee as well as the British Cardiac Society’s Council and Medical Practice Committee (chair).
Professor Fox has published over 400 papers in leading scientific journals. His expertise is in the understanding, investigation and treatment of angina; in particular the role of heart rate in the pathophysiology of myocardial ischaemia and infarction. He has played a major role in many important international clinical trials (EUROPA, IONA, BEAUTIFUL, HPS,ASCOT, SEARCH etc) that have changed the treatment of this condition. He is the acknowledged European expert in this field and consequently chaired the Task Force producing the European Angina Guidelines and chaired the committee responsible for the audit for the management of these patients in Europe.
Professor Fox has given plenary lectures to National Societies all over the world. He has given the “Finlayson Lecture” to the Royal College of Surgeons in Glasgow, the “St Cyres Lecture” to the British Cardiac Society, the “Andrea Cissalpino Lecture” to the Italian Cardiac Society and the “Stokes Lecture” to the Irish Cardiac Society. Professor Fox has been elected an honorary member of the French Cardiac Society and Japanese Circulation Society for his services to cardiology. He has been awarded the Mackenzie Medal of the British Cardiovascular Society, the Gold Medal of the European Society of Cardiology, the Chazov Medal of the Russian Federation of Cardiology and the Stokes Medal of the Irish Cardiac Society.
et al., THE INTRACRANIAL-B2LEED3S SCORE AND THE RISK OF INTRACRANIAL HEMORRHAGE IN ISCHAEMIC STROKE PATIENTS UNDER ANTIPLATELET TREATMENT (low Body mass index, Blood pressure, Lacune, Elderly, asian Ethnicity, cardiovascular Disease, cerebrovascular Disease, Dual antithrombotic treatment or anticoagulant, Sex), Cerebrovascular Diseases, ISSN:1421-9786
et al., 2017, Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events and Bleeding in Stable Coronary Artery Disease., Am J Med
et al., 2016, CMR Guidance for Recanalization of Coronary Chronic Total Occlusion, Jacc-cardiovascular Imaging, Vol:9, ISSN:1936-878X, Pages:547-556
Ferrari R, Fox K, 2016, Heart rate reduction in coronary artery disease and heart failure, Nature Reviews Cardiology, Vol:13, ISSN:1759-5002, Pages:493-+
et al., 2016, The treatment benefit of the ACE-inhibitor perindopril on top of beta-blocker therapy in patients with vascular disease, Congress of the European-Society-of-Cardiology (ESC), OXFORD UNIV PRESS, Pages:339-339, ISSN:0195-668X